About this compound
Tirzepatide is a synthetic 39-amino-acid peptide built on the GIP (glucose-dependent insulinotropic polypeptide) backbone and modified with a C20 fatty diacid side chain that binds albumin and extends its half-life in experimental systems. It is characterized in the literature as a dual agonist at the GIP and GLP-1 receptors.
Research literature studies tirzepatide in incretin receptor pharmacology, including in-vitro receptor binding and cAMP signaling assays, and in preclinical models of energy balance, glucose handling and body weight regulation.
Supplied as a lyophilized powder, 20mg per vial. Store sealed vials at -20°C, protected from light and moisture. For laboratory work the powder is reconstituted with bacteriostatic water or the buffer the protocol specifies; reconstituted material should be kept refrigerated and used within the stability window set by the research protocol.
For research use only. Not for human consumption, diagnostic, or therapeutic use.
GLP and Metabolic Peptides · 20mg
Earn 214 reward points on this vial with a free account. Sign in or join free
Dual GIP and GLP-1 receptor agonist, 39 amino acids. Lyophilized powder. Research use only.
Independent third-party testing
Batch certification
LotEC-TIRZ20-2026-033
The QR on every label opens all batch certificates; find the lot printed on your vial there, or type it here.
Published for every batch. No login required.
Discounts applied automatically at cart and checkout based on quantity. Mix and match bundles available across the catalog.
Subscribe and save
Choose how often Tirzepatide ships and pay $38.69 per vial instead of $42.99. Each delivery is invoiced like a normal order. Change the plan, skip a delivery, pause or cancel any time from your account.
One-time purchase at $42.99 per vial. Pick a plan to save 10% on every delivery.
Plan pricing is per vial. Quantity discounts do not stack with a plan.
Product details
What it is, how it is verified and how it ships. Every batch is tested by an accredited U.S. lab, and the certificate of analysis is published for anyone to read.
Tirzepatide is a synthetic 39-amino-acid peptide built on the GIP (glucose-dependent insulinotropic polypeptide) backbone and modified with a C20 fatty diacid side chain that binds albumin and extends its half-life in experimental systems. It is characterized in the literature as a dual agonist at the GIP and GLP-1 receptors.
Research literature studies tirzepatide in incretin receptor pharmacology, including in-vitro receptor binding and cAMP signaling assays, and in preclinical models of energy balance, glucose handling and body weight regulation.
Supplied as a lyophilized powder, 20mg per vial. Store sealed vials at -20°C, protected from light and moisture. For laboratory work the powder is reconstituted with bacteriostatic water or the buffer the protocol specifies; reconstituted material should be kept refrigerated and used within the stability window set by the research protocol.
For research use only. Not for human consumption, diagnostic, or therapeutic use.
Each batch is produced under strict quality controls with HPLC verification and full COA documentation. Supplied for research use only.
Dual verification on every batch: HPLC for purity, mass spectrometry for identity.
Every batch is tested by an accredited independent lab for identity, purity, sterility, and endotoxin levels. Every certificate is published below. No login required.
New lab reports appear within 24 hours of arriving from the lab.
Browse all lab results
All products are for research use only. Not for human consumption.
You must be at least 21 years of age to enter this site.
